Dexcom (DXCM) EBIAT (2016 - 2025)
Historic EBIAT for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $267.3 million.
- Dexcom's EBIAT rose 7620.3% to $267.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $836.3 million, marking a year-over-year increase of 4514.06%. This contributed to the annual value of $836.3 million for FY2025, which is 4514.06% up from last year.
- Per Dexcom's latest filing, its EBIAT stood at $267.3 million for Q4 2025, which was up 7620.3% from $283.8 million recorded in Q3 2025.
- Dexcom's 5-year EBIAT high stood at $283.8 million for Q3 2025, and its period low was -$5.3 million during Q4 2021.
- Over the past 5 years, Dexcom's median EBIAT value was $110.6 million (recorded in 2023), while the average stood at $125.6 million.
- Per our database at Business Quant, Dexcom's EBIAT crashed by 10128.86% in 2021 and then soared by 183207.55% in 2022.
- Dexcom's EBIAT (Quarter) stood at -$5.3 million in 2021, then skyrocketed by 1832.08% to $91.8 million in 2022, then skyrocketed by 179.19% to $256.3 million in 2023, then tumbled by 40.81% to $151.7 million in 2024, then soared by 76.2% to $267.3 million in 2025.
- Its EBIAT stands at $267.3 million for Q4 2025, versus $283.8 million for Q3 2025 and $179.8 million for Q2 2025.